Cargando…
Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development
The mRNA vaccines have been considered effective for combating cancer. However, the core components of the mRNA vaccines against head and neck squamous cell carcinoma (HNSCC) and the effects remain unclear. Our study aims to identify effective antigens in HNSCC to develop mRNA vaccines for correspon...
Autores principales: | Chen, Yan, Jiang, Ning, Chen, Meihua, Sui, Baiyan, Liu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714632/ https://www.ncbi.nlm.nih.gov/pubmed/36467412 http://dx.doi.org/10.3389/fcell.2022.1064754 |
Ejemplares similares
-
Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022) -
Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
por: Liu, Cong, et al.
Publicado: (2022) -
Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness
por: Zhang, Pei, et al.
Publicado: (2021) -
Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma
por: Zhang, Shichao, et al.
Publicado: (2022) -
Identification of the Immune-Related Genes in Tumor Microenvironment That Associated With the Recurrence of Head and Neck Squamous Cell Carcinoma
por: Chengcheng, Liu, et al.
Publicado: (2021)